ARCHIVES

Working Group To Review NCI Clinical Trials Programs

This article is from The Cancer Letter archive.

Vol. 22 No. 15 | April 12, 1996

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009

Saffiotti Quits As Carcinogenesis Chief With Blast At Rauscher, Peters

April 30, 1976

Cancer Incidence Rates For Recent Years Too Optimistic, NCI Researchers Find

October 25, 2002

ACCC/Oncology Economic Meeting to Examine DRGs, FCCs, Quality

August 9, 1985

Texts Of Workshop Report Summarized

November 8, 1996

Senate confirms Crawford as FDA commissioner.

July 22, 2005